or Try an Advanced Search...

    Technical Analysis for FTRE - Fortrea Holdings Inc.

    Grade Last Price % Change Price Change
    D 27.55 -0.93% -0.26
    FTRE closed down 0.93 percent on Friday, May 17, 2024, on 1.26 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical FTRE trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness -0.93%
    Wide Bands Range Expansion -0.93%
    Below Lower BB Weakness -0.93%
    Lower Bollinger Band Touch Weakness -0.93%
    Older End-of-Day Signals for FTRE ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day 1 day ago
    Down 1% 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    1.5x Volume Pace 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    FTRE Chart by TradingView
    Basic chart:

    Profile

    Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. It offers phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. is based in Durham, North Carolina.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Clinical Research Clinical Pharmacology Contract Research Organizations Patient Access Solutions

    Is FTRE a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Fortrea Appoints Machelle Sanders to Board of Directors
    May 14 An Intrinsic Calculation For Fortrea Holdings Inc. (NASDAQ:FTRE) Suggests It's 48% Undervalued
    May 14 Fortrea Holdings First Quarter 2024 Earnings: Misses Expectations
    May 14 Fortrea Holdings Inc (FTRE) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
    May 13 Tech Stocks Inch Higher Ahead Of Key Inflation Data, GameStop Skyrockets, Tencent Fuels China Rally: What's Driving Markets Monday?
    May 13 Fortrea Holdings (FTRE) Q1 2024 Earnings Call Transcript
    May 13 Fortrea Holdings Inc. 2024 Q1 - Results - Earnings Call Presentation
    May 13 Fortrea Holdings Non-GAAP EPS of -$0.04 misses by $0.04, revenue of $662.1M misses by $92.48M
    May 13 Fortrea Reports First Quarter 2024 Results
    May 12 Fortrea Holdings: Still Many Question Marks On This CRO Play
    See more FTRE news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 41.02
    52 Week Low 24.925
    Average Volume 1,137,342
    200-Day Moving Average 32.23
    50-Day Moving Average 36.92
    20-Day Moving Average 34.30
    10-Day Moving Average 31.82
    Average True Range 1.65
    RSI (14) 23.08
    ADX 31.79
    +DI 9.23
    -DI 45.88
    Chandelier Exit (Long, 3 ATRs) 33.09
    Chandelier Exit (Short, 3 ATRs) 31.58
    Upper Bollinger Bands 41.58
    Lower Bollinger Band 27.02
    Percent B (%b) 0.04
    BandWidth 42.46
    MACD Line -2.44
    MACD Signal Line -1.52
    MACD Histogram -0.9208
    Fundamentals Value
    Market Cap 2.45 Billion
    Num Shares 88.8 Million
    EPS 0.06
    Price-to-Earnings (P/E) Ratio 459.17
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 29.02
    Resistance 3 (R3) 29.15 28.78 28.78
    Resistance 2 (R2) 28.78 28.41 28.72 28.69
    Resistance 1 (R1) 28.17 28.18 27.99 28.04 28.61
    Pivot Point 27.80 27.80 27.71 27.74 27.80
    Support 1 (S1) 27.19 27.43 27.01 27.06 26.49
    Support 2 (S2) 26.82 27.20 26.76 26.41
    Support 3 (S3) 26.21 26.82 26.33
    Support 4 (S4) 26.08